BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 12748801)

  • 1. [Diabetic retinopathy. Pathophysiology and therapy of hypoxia-induced inflammation].
    Joussen AM; Fauser S; Krohne TU; Lemmen KD; Lang GE; Kirchhof B
    Ophthalmologe; 2003 May; 100(5):363-70. PubMed ID: 12748801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy.
    Pruneau D; Bélichard P; Sahel JA; Combal JP
    Curr Opin Investig Drugs; 2010 May; 11(5):507-14. PubMed ID: 20419596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connection of pericyte-angiopoietin-Tie-2 system in diabetic retinopathy: friend or foe?
    Cai J; Ruan Q; Chen ZJ; Han S
    Future Med Chem; 2012 Nov; 4(17):2163-76. PubMed ID: 23190105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal capillary pericyte apoptosis in early human diabetic retinopathy.
    Li W; Yanoff M; Liu X; Ye X
    Chin Med J (Engl); 1997 Sep; 110(9):659-63. PubMed ID: 9642318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal O-linked N-acetylglucosamine protein modifications: implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy.
    Gurel Z; Sieg KM; Shallow KD; Sorenson CM; Sheibani N
    Mol Vis; 2013; 19():1047-59. PubMed ID: 23734074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal hypoxia in long-term diabetic cats.
    Linsenmeier RA; Braun RD; McRipley MA; Padnick LB; Ahmed J; Hatchell DL; McLeod DS; Lutty GA
    Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1647-57. PubMed ID: 9699554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-hypoxic constriction of retinal arterioles is impaired during nitric oxide and cyclo-oxygenase inhibition and in diabetic patients without retinopathy.
    Petersen L; Bek T
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1965-1971. PubMed ID: 28752370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal overexpression of angiopoietin-2 mimics diabetic retinopathy and enhances vascular damages in hyperglycemia.
    Pfister F; Wang Y; Schreiter K; vom Hagen F; Altvater K; Hoffmann S; Deutsch U; Hammes HP; Feng Y
    Acta Diabetol; 2010 Mar; 47(1):59-64. PubMed ID: 19238311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pericytes and the pathogenesis of diabetic retinopathy.
    Hammes HP
    Horm Metab Res; 2005 Apr; 37 Suppl 1():39-43. PubMed ID: 15918109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From pathobiology to the targeting of pericytes for the treatment of diabetic retinopathy.
    Arboleda-Velasquez JF; Valdez CN; Marko CK; D'Amore PA
    Curr Diab Rep; 2015 Feb; 15(2):573. PubMed ID: 25620405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human retinal microvascular endothelial-pericyte co-culture model to study diabetic retinopathy in vitro.
    Eyre JJ; Williams RL; Levis HJ
    Exp Eye Res; 2020 Dec; 201():108293. PubMed ID: 33039459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylglyoxal-induced imbalance in the ratio of vascular endothelial growth factor to angiopoietin 2 secreted by retinal pigment epithelial cells leads to endothelial dysfunction.
    Bento CF; Fernandes R; Matafome P; Sena C; Seiça R; Pereira P
    Exp Physiol; 2010 Sep; 95(9):955-70. PubMed ID: 20562294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating Microaneurysm Pathophysiology in Diabetic Retinopathy Through Objective Analysis of Capillary Nonperfusion, Inflammation, and Pericytes.
    An D; Tan B; Yu DY; Balaratnasingam C
    Diabetes; 2022 Apr; 71(4):733-746. PubMed ID: 35043147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of retinal capillary basement membrane thickening in diabetic dogs by a non-steroidal anti-inflammatory drug.
    Gardiner TA; Anderson HR; Degenhardt T; Thorpe SR; Baynes JW; Archer DB; Stitt AW
    Diabetologia; 2003 Sep; 46(9):1269-75. PubMed ID: 12861449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current hypotheses for the biochemical basis of diabetic retinopathy.
    Mandarino LJ
    Diabetes Care; 1992 Dec; 15(12):1892-901. PubMed ID: 1464244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What is the etiology of diabetic retinopathy?].
    Wiedemann P
    Ophthalmologe; 1993 Oct; 90(5):426-33. PubMed ID: 8219625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current views on the development of diabetic retinopathy].
    Sosna T
    Cas Lek Cesk; 2002 Nov; 141(22):697-701. PubMed ID: 12532906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased numbers of caveolae in retinal endothelium and pericytes in hypertensive diabetic rats.
    Hillman N; Cox S; Noble AR; Gallagher PJ
    Eye (Lond); 2001 Jun; 15(Pt 3):319-25. PubMed ID: 11450729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial proliferation in diabetic retinal microaneurysms.
    Aguilar E; Friedlander M; Gariano RF
    Arch Ophthalmol; 2003 May; 121(5):740-1. PubMed ID: 12742861
    [No Abstract]   [Full Text] [Related]  

  • 20. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.